EE9600020A - 9-asendatud 2-(2-n-alkoksüfenüül)puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid - Google Patents
9-asendatud 2-(2-n-alkoksüfenüül)puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimidInfo
- Publication number
- EE9600020A EE9600020A EE9600020A EE9600020A EE9600020A EE 9600020 A EE9600020 A EE 9600020A EE 9600020 A EE9600020 A EE 9600020A EE 9600020 A EE9600020 A EE 9600020A EE 9600020 A EE9600020 A EE 9600020A
- Authority
- EE
- Estonia
- Prior art keywords
- medicaments
- alkoxyphenyl
- purin
- ones
- substituted
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- UYLWKSJTHLRFBX-UHFFFAOYSA-N purin-6-one Chemical class O=C1N=CN=C2N=CN=C12 UYLWKSJTHLRFBX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19501480A DE19501480A1 (de) | 1995-01-19 | 1995-01-19 | 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9600020A true EE9600020A (et) | 1996-08-15 |
Family
ID=7751828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9600020A EE9600020A (et) | 1995-01-19 | 1996-01-18 | 9-asendatud 2-(2-n-alkoksüfenüül)puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5866571A (fr) |
| EP (1) | EP0722943A1 (fr) |
| JP (1) | JPH08231546A (fr) |
| KR (1) | KR960029335A (fr) |
| CN (1) | CN1138583A (fr) |
| AR (1) | AR002704A1 (fr) |
| AU (1) | AU4097796A (fr) |
| BG (1) | BG61729B1 (fr) |
| BR (1) | BR9600149A (fr) |
| CA (1) | CA2167349A1 (fr) |
| CO (1) | CO4700524A1 (fr) |
| CZ (1) | CZ16896A3 (fr) |
| DE (1) | DE19501480A1 (fr) |
| EE (1) | EE9600020A (fr) |
| FI (1) | FI960226A7 (fr) |
| HR (1) | HRP960009A2 (fr) |
| HU (1) | HUP9600107A3 (fr) |
| IL (1) | IL116771A (fr) |
| MA (1) | MA23779A1 (fr) |
| NO (1) | NO960221L (fr) |
| NZ (1) | NZ280829A (fr) |
| PE (1) | PE10597A1 (fr) |
| PL (1) | PL312353A1 (fr) |
| SG (1) | SG47379A1 (fr) |
| SK (1) | SK7696A3 (fr) |
| SV (1) | SV1996000004A (fr) |
| TN (1) | TNSN96005A1 (fr) |
| TR (1) | TR199600701A2 (fr) |
| YU (1) | YU2896A (fr) |
| ZA (1) | ZA96399B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6064072A (en) * | 1997-05-12 | 2000-05-16 | Cymer, Inc. | Plasma focus high energy photon source |
| DE19838300A1 (de) * | 1998-08-24 | 2000-03-02 | Bayer Ag | 9-Dialkylaminopurinon-derivate |
| US6268372B1 (en) | 1998-09-11 | 2001-07-31 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones |
| US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
| GB9924020D0 (en) * | 1999-10-11 | 1999-12-15 | Pfizer Ltd | Pharmaceutically active compounds |
| AUPQ515700A0 (en) * | 2000-01-19 | 2000-02-10 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole compounds |
| ES2381862T3 (es) * | 2000-09-06 | 2012-06-01 | Mitsubishi Tanabe Pharma Corporation | Preparaciones para administración por vía oral |
| NZ527585A (en) * | 2001-02-15 | 2005-04-29 | Tanabe Seiyaku Co | Tablets quickly disintegrated in oral cavity |
| US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
| WO2003053975A1 (fr) * | 2001-12-13 | 2003-07-03 | Daiichi Suntory Pharma Co., Ltd. | Derives de pyrazolopyrimidinone possedant une activite inhibitrice de pde7 |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| AU2003226149A1 (en) * | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Substituted aryl amides |
| WO2015200177A1 (fr) | 2014-06-23 | 2015-12-30 | Celgene Corporation | Utilisation d'aprémilast pour le traitement d'une maladie hépatique ou d'une anomalie de la fonction hépatique |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| CA1303037C (fr) * | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Derives de purinone utilises comme bronchodilatateurs,vasodilatateurs et agents anti-allergiques |
| GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
| GB9126260D0 (en) * | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
| US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
| US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
| GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
-
1995
- 1995-01-19 DE DE19501480A patent/DE19501480A1/de not_active Withdrawn
-
1996
- 1996-01-08 HR HR19501480.4A patent/HRP960009A2/hr not_active Application Discontinuation
- 1996-01-08 EP EP96100153A patent/EP0722943A1/fr not_active Withdrawn
- 1996-01-12 TR TR96/00023A patent/TR199600701A2/xx unknown
- 1996-01-15 AU AU40977/96A patent/AU4097796A/en not_active Abandoned
- 1996-01-16 IL IL11677196A patent/IL116771A/xx not_active IP Right Cessation
- 1996-01-16 NZ NZ280829A patent/NZ280829A/en unknown
- 1996-01-16 US US08/585,996 patent/US5866571A/en not_active Expired - Fee Related
- 1996-01-16 CA CA002167349A patent/CA2167349A1/fr not_active Abandoned
- 1996-01-17 FI FI960226A patent/FI960226A7/fi unknown
- 1996-01-17 PL PL96312353A patent/PL312353A1/xx unknown
- 1996-01-17 SG SG1996000262A patent/SG47379A1/en unknown
- 1996-01-17 TN TNTNSN96005A patent/TNSN96005A1/fr unknown
- 1996-01-18 YU YU2896A patent/YU2896A/sh unknown
- 1996-01-18 JP JP8023474A patent/JPH08231546A/ja active Pending
- 1996-01-18 CZ CZ96168A patent/CZ16896A3/cs unknown
- 1996-01-18 ZA ZA96399A patent/ZA96399B/xx unknown
- 1996-01-18 NO NO960221A patent/NO960221L/no unknown
- 1996-01-18 BR BR9600149A patent/BR9600149A/pt active Search and Examination
- 1996-01-18 SK SK76-96A patent/SK7696A3/sk unknown
- 1996-01-18 BG BG100291A patent/BG61729B1/bg unknown
- 1996-01-18 HU HU9600107A patent/HUP9600107A3/hu unknown
- 1996-01-18 EE EE9600020A patent/EE9600020A/xx unknown
- 1996-01-18 MA MA24134A patent/MA23779A1/fr unknown
- 1996-01-18 KR KR1019960001003A patent/KR960029335A/ko not_active Withdrawn
- 1996-01-19 PE PE1996000045A patent/PE10597A1/es not_active Application Discontinuation
- 1996-01-19 SV SV1996000004A patent/SV1996000004A/es unknown
- 1996-01-19 CN CN96101805A patent/CN1138583A/zh active Pending
- 1996-01-19 CO CO96002170A patent/CO4700524A1/es unknown
- 1996-01-19 AR ARP960101086A patent/AR002704A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE10597A1 (es) | 1997-06-13 |
| NO960221D0 (no) | 1996-01-18 |
| MA23779A1 (fr) | 1996-10-01 |
| NZ280829A (en) | 1998-04-27 |
| YU2896A (sh) | 1999-03-04 |
| CO4700524A1 (es) | 1998-12-29 |
| HRP960009A2 (en) | 1997-12-31 |
| JPH08231546A (ja) | 1996-09-10 |
| EP0722943A1 (fr) | 1996-07-24 |
| AR002704A1 (es) | 1998-04-29 |
| IL116771A (en) | 1999-06-20 |
| PL312353A1 (en) | 1996-07-22 |
| CA2167349A1 (fr) | 1996-07-20 |
| NO960221L (no) | 1996-07-22 |
| ZA96399B (en) | 1996-08-14 |
| DE19501480A1 (de) | 1996-07-25 |
| SV1996000004A (es) | 1997-02-19 |
| FI960226A7 (fi) | 1996-07-20 |
| BR9600149A (pt) | 1998-01-06 |
| HU9600107D0 (en) | 1996-03-28 |
| FI960226A0 (fi) | 1996-01-17 |
| SG47379A1 (en) | 1998-04-17 |
| TNSN96005A1 (en) | 2005-03-15 |
| CZ16896A3 (en) | 1996-08-14 |
| IL116771A0 (en) | 1996-05-14 |
| SK7696A3 (en) | 1996-08-07 |
| KR960029335A (ko) | 1996-08-17 |
| HUP9600107A3 (en) | 1999-06-28 |
| AU4097796A (en) | 1996-07-25 |
| TR199600701A2 (tr) | 1996-08-21 |
| HUP9600107A2 (en) | 1997-05-28 |
| BG61729B1 (bg) | 1998-04-30 |
| CN1138583A (zh) | 1996-12-25 |
| BG100291A (bg) | 1996-07-31 |
| US5866571A (en) | 1999-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9600019A (et) | 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9700019A (et) | 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9700043A (et) | Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9700031A (et) | Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9700153A (et) | Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9600018A (et) | 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE04021B1 (et) | 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
| EE9700044A (et) | Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid. | |
| EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
| FI903215A7 (fi) | Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä | |
| EE9700020A (et) | Heteroaatomit sisaldavad tsülopentaanpüridüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9700060A (et) | 2-arüül-asendatud püridiinid,nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| FI953981A7 (fi) | 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi | |
| EE03399B1 (et) | Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess | |
| CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| FI911584A7 (fi) | Substituoituja atsoleja, menetelmä niiden valmistamiseksi, näitä sisältäviä aineita ja niiden käyttö | |
| EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
| FI973868L (fi) | D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyperparatyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa | |
| EE9600030A (et) | N-(3-bensofuranüül)karbamiidderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
| FI940810L (fi) | Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| BR9105406A (pt) | Benzodiazepinonas,compostos,cetonas,processo para a preparacao de compostos,medicamento e uso | |
| FI915381A7 (fi) | Substituoituja atsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| EE03878B1 (et) | 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks | |
| FI913957A7 (fi) | 6,7-dihydro-3-fenyyli-1,2-bentsisoksatsol-4(5H)-oneja ja -oleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä |